Novartis International AG / Novartis announces US FDA approval of Xolair® for chronic idiopathic urticaria (CIU) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
- Dec 29 Mon 2014 05:57
-
Novartis announces US FDA approval of Xolair(R) for chronic idiopathic urticaria (CIU)
- Dec 29 Mon 2014 05:56
-
Tempers flare as mass flood evacuations begin in Kashmir
Floods that have killed 450 people in India and Pakistan began to recede on Wednesday giving rescue teams a chance to evacuate thousands of villagers stranded by the heaviest rainfall in 50 years in the heavily militarized and disputed region of Kashmir.
On the Indian side of the divided region, floods and landslides have cut off more than 1 million people from basic services, triggering a massive military rescue operation that has so far evacuated 80,000 from villages and city rooftops.
Tempers rose on Wednesday with some angry that relief efforts were only reaching them six days after the floods began. Others complained about living conditions in temporary camps.
Villagers heckled some soldiers and beat a rescue official who was airlifted for emergency treatment.
The flooding is the first major humanitarian emergency under Prime Minister Narendra Modi, and also comes at a difficult time for Pakistani Prime Minister Nawaz Sharif, who has faced weeks of street protests aimed at forcing him out.
- Dec 29 Mon 2014 05:55
-
What to Watch in the Week Ahead and on Monday, Oct. 13
(The Day Ahead is an email and PDF publication that includes the day's major stories and
events, analyses and other features. To receive The Day Ahead, Eikon users can register at
. Thomson One users can register at RT/DAY/US. All times in ET/GMT)
WEEK AHEAD
Investors look forward to a week full of earnings reports that could either push the market
- Dec 29 Mon 2014 05:54
-
Beacon Hill Launches New Division - Beacon Hill Pharma
- Dec 29 Mon 2014 05:54
-
ASLA Survey Shows Business Conditions for Landscape Architects Holding Steady
ASLA Survey Shows Business Conditions for Landscape Architects Holding Steady Billable hours rise; inquiries for new work, hiring plans fall slightly
- Dec 29 Mon 2014 05:53
-
Wave Systems to Present at Craig-Hallum Alpha Select Conference Thursday, September 18
Wave Systems to Present at Craig-Hallum Alpha Select Conference Thursday, September 18
Presentation Webcast Live and Available for Replay
- Dec 29 Mon 2014 05:52
-
COMS Interactive Acquires Directed Medical Systems
COMS Interactive Acquires Directed Medical Systems Extends Daylight IQ™ Product Set to Include Advance Care Directives
- Dec 29 Mon 2014 05:52
-
Verde Media Group Inc. CEO, William Veve, Interviewed Live on ABC Radio's "The Amilya Show" to Introduce BeautyJect Inc.
NEW YORK, July 23, 2014 (GLOBE NEWSWIRE) -- Verde Media Group Inc. (OTC:VMGI) is an emerging growth biotechnology company. Through its subsidiary, Beautyject Inc., it will provide needle-free injectable devices with a unique patented technology and design. Verde Media CEO, William Veve introduced the product prior to its official launch in North and South American markets during the months to come. Mr. Veve was interviewed live by host Amilya Antonetti on ABC Talk Radio's "The Amilya Show."
The cosmetic needle-free products will be marketed in clinical form for professionals. However, the company is looking to its over-the-counter delivery system for consumer use as its most lucrative product line. Boutique marketing firm, Power Shark Capital, advised by Kevin Harrington from ABC's series, "Shark Tank," will be orchestrating the official large-scale release of the product as well as sales and distribution functions in conjunction with Verde.
In the exclusive interview, Mr. Veve discussed the company's subsidiary BeautyJect, Inc., commenting specifically, "on its new needle-free, over-the-counter cosmetic injectable devices and needle-free syringes." The interview also delved into the application of these products and the feedback expected by healthcare communities embracing the introduction of needle-free devices.
- Dec 29 Mon 2014 05:51
-
Diageo Honored By Connecticut Chapter of Lambda Legal for Commitment to LGBT Equality
Diageo Honored By Connecticut Chapter of Lambda Legal for Commitment to LGBT Equality Recognition Highlights Diageo's Support of LGBT Community and Inclusive Corporate Policies
- Dec 29 Mon 2014 05:50
-
Boston Islamic Society confirms outbursts by bombing suspect
One of the men suspected in the Boston Marathon bombing twice disrupted sermons to challenge views expressed by preachers leading services at a local mosque, the Islamic Society of Boston said on Monday.
But the suspect, named by the FBI as Tamerlan Tsarnaev, and his younger brother, Dzhokhar, "never expressed any hint of violent sentiments or behavior," the group said in a statement. "If they had, the FBI would have immediately been called."
Tamerlan, suspected of planting one of two bombs that killed three people and wounded more than 200 at the marathon, was killed in a shoot out with police on Thursday. Dzhokhar, taken into custody a day later, allegedly planted the second bomb, according to a federal criminal complaint filed on Monday.
Neither of the ethnic Chechen brothers was a member or regular attendee of the Cambridge, Massachusetts, mosque, it said.
The older brother first interrupted a sermon at the society's mosque in Cambridge on November 16, 2012, objecting to a preacher's call for Muslims to celebrate holidays like July 4th and Thanksgiving just like the birthday of the Prophet Muhammad, the society said.
- Dec 15 Mon 2014 05:12
-
UPDATE 2-Balfour Beatty shares slump on engineering profit warning